NervGen Pharma's total assets for Q2 2025 were C$16.92M, an increase of 6.85% from the previous quarter. TSE:NGEN total liabilities were C$17.84M for the fiscal quarter, a 23.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.